Bruker (BRKRP) Gains from Investment Securities (2010 - 2026)

Bruker has reported Gains from Investment Securities for 17 years, with the latest figure at -$500000.0 in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 100.75% year-over-year to -$500000.0; the trailing twelve-month figure through Mar 2026 stood at -$71.7 million (down 299.17% YoY), and the FY2025 full-year result was $3.9 million, down 29.48% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at -$500000.0, up from -$38.5 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $66.4 million in Q1 2025, with the low at -$66.0 million in Q2 2025.
• Historically, Gains from Investment Securities has averaged $956540.7 across 5 years, with a median of $1.3 million in 2022.
• The largest YoY upside for Gains from Investment Securities was 1925.0% in 2023 against a maximum downside of 2312.19% in 2023.
• Bruker's Gains from Investment Securities stood at $10.1 million in 2022, then soared by 290.1% to $39.4 million in 2023, then plunged by 114.47% to -$5.7 million in 2024, then plunged by 575.44% to -$38.5 million in 2025, then surged by 98.7% to -$500000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$500000.0 (Q1 2026), -$38.5 million (Q4 2025), and $33.3 million (Q3 2025), per Business Quant data.